These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24219216)

  • 41. Polymyalgia rheumatica: evidence for a hypothalamic-pituitary-adrenal axis-driven disease.
    Cutolo M; Straub RH
    Clin Exp Rheumatol; 2000; 18(6):655-8. PubMed ID: 11138324
    [No Abstract]   [Full Text] [Related]  

  • 42. Dementia, ageing, and the stress control system.
    Orrell MW; O'Dwyer AM
    Lancet; 1995 Mar; 345(8951):666-7. PubMed ID: 7885120
    [No Abstract]   [Full Text] [Related]  

  • 43. Sundowning syndrome: a possible marker of frailty in Alzheimer's disease?
    Ferrazzoli D; Sica F; Sancesario G
    CNS Neurol Disord Drug Targets; 2013 Jun; 12(4):525-8. PubMed ID: 23574165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "Sundowning" and other temporally associated agitation states in dementia patients.
    Bachman D; Rabins P
    Annu Rev Med; 2006; 57():499-511. PubMed ID: 16409163
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased glucocorticoid production and altered cortisol metabolism in women with mild to moderate Alzheimer's disease.
    Rasmuson S; Andrew R; Näsman B; Seckl JR; Walker BR; Olsson T
    Biol Psychiatry; 2001 Mar; 49(6):547-52. PubMed ID: 11257240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fenfluramine challenge test as a marker of serotonin activity in patients with Alzheimer's dementia and agitation.
    Mintzer J; Brawman-Mintzer O; Mirski DF; Unger R; Nietert P; Meeks A; Sampson R
    Biol Psychiatry; 1998 Nov; 44(9):918-21. PubMed ID: 9807649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy.
    Mahlberg R; Kunz D; Sutej I; Kühl KP; Hellweg R
    J Clin Psychopharmacol; 2004 Aug; 24(4):456-9. PubMed ID: 15232344
    [No Abstract]   [Full Text] [Related]  

  • 48. Individualized music intervention protocol.
    Gerdner LA
    J Gerontol Nurs; 1999 Oct; 25(10):10-6. PubMed ID: 10776148
    [No Abstract]   [Full Text] [Related]  

  • 49. Agitated confusional states in patients with right hemisphere infarctions.
    Schmidley JW; Messing RO
    Stroke; 1984; 15(5):883-5. PubMed ID: 6474540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comforting a confused patient.
    Hilgers J
    Nursing; 2003 Jan; 33(1):48-50. PubMed ID: 12544564
    [No Abstract]   [Full Text] [Related]  

  • 51. Hashimoto's encephalitis.
    Sunil GS; Mariash CN
    J Clin Endocrinol Metab; 2001 Feb; 86(2):947. PubMed ID: 11158076
    [No Abstract]   [Full Text] [Related]  

  • 52. Sundown syndrome: etiology and management.
    Burney-Puckett M
    J Psychosoc Nurs Ment Health Serv; 1996 May; 34(5):40-3. PubMed ID: 8732982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What is sundowning?
    Bliwise DL
    J Am Geriatr Soc; 1994 Sep; 42(9):1009-11. PubMed ID: 8064089
    [No Abstract]   [Full Text] [Related]  

  • 54. Pain: cause of agitation in elderly individuals with dementia.
    Geda YE; Rummans TA
    Am J Psychiatry; 1999 Oct; 156(10):1662-3. PubMed ID: 10518184
    [No Abstract]   [Full Text] [Related]  

  • 55. Research on psychoimmunology.
    Cazzullo CL; Trabattoni D; Saresella M; Annoni G; Arosio B; Clerici M
    World J Biol Psychiatry; 2003 Jul; 4(3):119-23. PubMed ID: 12872205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-associated endocrine dysfunctions and approaches to their correction.
    Goncharova ND; Lapin BA; Khavinson VKh
    Bull Exp Biol Med; 2002 Nov; 134(5):417-21. PubMed ID: 12802438
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Mental confusion with anxiety and agitation in cat-scratch disease].
    Michel D; Antoine JC; Lucht F; Convers P; Bouchou A; Claudy A; Laurent B
    Presse Med; 1991 Mar; 20(11):520. PubMed ID: 1827194
    [No Abstract]   [Full Text] [Related]  

  • 58. Reversible MRI changes of hypothalamus in a multiple sclerosis patient with homeostatic disturbances.
    Tsui EY; Yip SF; Ng SH; Cheung YK
    Eur Radiol; 2002 Dec; 12 Suppl 3():S28-31. PubMed ID: 12522597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The hypothalamic-pituitary-gonadal axis and the enigma of Alzheimer disease sex differences.
    Sauvé F; Kacimi L; Prévot V
    Nat Rev Endocrinol; 2024 Jun; 20(6):317-318. PubMed ID: 38514817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Commentary on "Cannabinoids for Agitation in Alzheimer's Disease".
    Goveas JS
    Am J Geriatr Psychiatry; 2021 Dec; 29(12):1264-1266. PubMed ID: 33839012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.